查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1525476

全球神经血管设备市场评估：依产品、依应用、依规模、依最终用户、依地区、机会、预测，2017-2031年

Neurovascular Devices Market Assessment, By Product, By Application, By Size, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 232 Pages | 商品交期: 3-5个工作天内

价格

全球神经血管设备市场规模将从2023年的33.5亿美元成长到2031年的61.1亿美元，在2024-2031年的预测期内年复合成长率为7.80%。神经血管器材市场是医疗器材产业的重要组成部分，在医疗器材产业中成长最快。神经系统疾病盛行率上升、微创手术采用率上升以及技术进步等因素推动市场发展。

脑动静脉畸形（AVM）和脑动脉瘤是使用神经血管装置治疗脑血管异常的两个例子。脑栓塞和动脉瘤弹簧圈栓塞是神经血管装置的两个重要类别。这些细小的线被盘绕起来，透过填充动脉瘤口袋并阻止血流而放入动脉瘤中。2023年，栓塞弹簧圈最常用于治疗脑动脉瘤。脑血管成形术和支架系统用于疏通大脑中阻塞或受限的动脉，是神经血管装置的重要组成部分。这些装置包括放置支架以保持动脉开放，以及球囊导管（透过充气以扩大动脉）。在急性缺血性中风中，神经血栓切除装置用于清除大脑阻塞动脉中的血块。支架回收器和抽吸导管是两个例子。经桡动脉连接装置使用手腕中的桡动脉来连接大脑中的动脉，而不是使用腹股沟中的股动脉。这种方法可以缩短患者的恢復期并最大限度地减少问题。

神经血管疾病盛行率的上升是刺激神经血管医疗器材需求的主要因素。根据疾病预防控制中心的资料，55岁以后，每10年中风的次数就会增加一倍。由于人口老化、吸烟、肥胖、高血压等因素，神经血管疾病的全球发生率不断增加。为了改善这些神经系统疾病的诊断、监测和治疗，针对神经血管疾病的患者群体的规模和快速扩张大幅促进了神经血管设备和介入治疗的采用。根据世界中风说明书的资料，大约有 1.01 亿人经历中风。 15 岁至 49 岁之间的人占中风倖存者的 22%。

本报告调查了全球神经血管设备市场，并提供了市场概述，包括依产品、应用、规模、最终用户、地区划分的趋势以及参与该市场的公司的概况。

目录

第1章 研究方法

第2章 专案范围与定义

第3章 执行摘要

第4章 2017-2031年全球神经血管设备市场前景

  • 市场规模与预测
  • 依产品
  • 依用途
  • 依尺寸
  • 依最终用户
  • 依地区
  • 各公司的市占率（%），2023年

第5章 2017-2031年全球神经血管设备市场前景（依地区）

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东、非洲

第6章 市场地图，2023年

第7章 宏观环境与产业结构

  • 需求与供给分析
  • 汇入/汇出分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第8章 市场动态

第9章 监理架构与创新

第10章 主要参会企业状况

第11章 价格分析

第12章 案例研究

第13章 主要进入者展望

  • Medtronic Plc
  • Penumbra Inc.
  • Stryker Corporation
  • Johnson & Johnson Services Inc.
  • Microport Scientific Corporation
  • Terumo Corporation
  • Acandis GmbH
  • NeuroVasc Technologies Inc.
  • Asahi Intecc USA Inc.
  • Integra Lifesciences Corporation

第14章 策略建议

第15章 查询及免责声明

Product Code: MX11697

Global neurovascular devices market is projected to witness a CAGR of 7.80% during the forecast period 2024-2031, growing from USD 3.35 billion in 2023 to USD 6.11 billion in 2031. The neurovascular devices market is an important part of the medical device industry, accounting for one of the fastest growth rates in the medical device industry. Factors are driving the market such as increasing prevalence of neurological disorders, rising adoption of minimally invasive surgeries, and technological advancements.

Arteriovenous malformations (AVMs) and cerebral aneurysms are two instances of blood vessel abnormalities in the brain that are treated with neurovascular devices. Cerebral embolization and aneurysm coiling devices are two important categories of neurovascular devices. By filling the pocket and obstructing blood flow, these tiny wires are coiled and placed into the aneurysm. In 2023, embolization coils were used the most for treating brain aneurysms. Cerebral angioplasty and stenting systems, which are used to unblock blocked or restricted arteries in the brain are an important part of neurovascular devices. These devices include stents, which are placed to keep the artery open, and balloon catheters, which are inflated to enlarge the artery. During an acute ischemic stroke, blood clots are removed from blocked arteries in the brain using neurothrombectomy devices. Stent retrievers and aspiration catheters are two instances of these devices. Instead of using the femoral artery in the groin, transradial access devices use the radial artery in the wrist to access the brain's arteries. This method reduces the patient's recovery period and minimizes problems.

In June 2024, Medtronic announced the launch of Artisse intrasaccular device for treating intercranial aneurysms. The launch took place at the same time when preliminary data about the device's performance, safety, and efficacy were made public for the first time at LINNC Paris 2024. Artisse was developed to meet the demands of patients with complicated wide-neck bifurcation aneurysms that were previously treated with intrasaccular basket devices, coil adjunctive neck-bridging devices, and stent-assisted coiling.

Increasing Prevalence of Neurovascular Diseases

The growing prevalence of neurovascular diseases is a key driver fueling the demand for neurovascular medical devices. According to CDC data, the chance of a stroke doubles every ten years after turning 55 years old. The global incidence of neurovascular illness is on the rise due to factors such as the aging population, smoking, obesity, and high blood pressure. To improve diagnosis, monitoring, and treatment of these neurological diseases, the adoption of neurovascular devices and interventional therapeutic procedures is being greatly aided by the sizeable and quickly expanding patient base for targeting neurovascular diseases. According to data from the global stroke fact sheet, approximately 101 million individuals have experienced stroke. 15 to 49-year-olds make up 22% of those who have had a stroke and are still alive.

Technological Advancements to Evolve Neurovascular Devices Market

Innovations in the medical device industry are associated with the development of novel methods, procedures, or technology for the diagnosis, treatment, and management of illness in response to the need for improved patient outcomes and lower healthcare expenses. Medical device companies are continuing to innovate in the neurovascular device industry, concentrating their research and development efforts on advanced technologies that have the potential to enhance outcomes and support the growth of the ischemic and hemorrhagic stroke devices. SmartTRAK identified emerging technologies that could potentially disrupt the neurovascular devices market over the next two to five years in two recent neurointerventional meetings, the 14th European Society for Minimally Invasive Neurological Therapy (ESMINT) Congress 2022 and the 19th Annual Meeting of the Society for NeuroInterventional Surgery (SNIS). It includes new methods of aspiration for the treatment of acute ischemic stroke (AIS), novel intrasaccular flow interruption devices, and supporting technology for neurointerventional treatments.

Cerebral Embolization and Aneurysm Coiling Devices Dominate the Global Neurovascular Devices Market

Cerebral embolization and aneurysm coiling devices dominate the global neurovascular devices market. Brain aneurysms that were previously thought to be incurable can be treated using minimally invasive coil embolization. Compared to open surgery, this approach for the treatment of aneurysms is less invasive and needs a considerably shorter recovery period. Better outcomes can be achieved from coil embolization of small aneurysms with narrow necks than from embolization of big or enormous aneurysms with broad necks. Over 80% of aneurysms treated with coil embolization have proven permanent success in the long term. In August 2023, Microport Neurotech received marketing approval for numen coil embolization system. Numen is categorized as a Category IV high-risk medical device, implying that registering it requires a high level of expertise. The Japanese authorities have approved this neurointerventional device, highlighting its innovative clinical design and excellent performance.

Asia-Pacific is Expected to Grow at the Fastest Rate in the Forecast Period

Asia-Pacific is anticipated to witness a significant growth in the demand for neurovascular devices in the forecast period. The primary drivers for the growth of neurovascular devices in Asia-Pacific are the rising prevalence of neurovascular diseases, growth in adoption of minimally invasive surgeries and geriatric population. Neurovascular diseases that may impact the blood artery network around the brain, results in ailments such as aneurysms and strokes that are treated with neurovascular devices. Increasing awareness of neurovascular procedures and a sizable patient base due to neurovascular illnesses are crucial reasons driving the market expansion in Asia-Pacific. In India, stroke is the second most prevalent cause of death. India encounters about 1,85,000 strokes annually, with one stroke occurring roughly every forty seconds and related mortality occurring every four minutes.

Future Market Scenario (2024-2031F)

The future of neurovascular devices looks promising, driven by advancements in technology and the growing prevalence of neurovascular conditions. Cerebral embolization and aneurysm coiling devices are expected to remain a key focus area, as these thin wire coils that fill and block blood flow to aneurysms continue to be the most preferred treatment methods. Cerebral angioplasty and stenting systems are poised for growth, as they are used to open narrowed or blocked arteries in the brain. Innovations in these devices, such as the development of flow diversion stents, are allowing for more precise and controlled placement during procedures.

Key Players Landscape and Outlook

Several medical device companies are flourishing in the neurovascular devices market by planning and adopting new strategies. They are complying with new strategic initiatives for neurovascular devices to increase their market presence. New agreements, contracts, acquisitions mergers, investments, and partnerships are major ways through which the market players are trying to achieve higher market share.

EndoStream Medical announced in February 2023, that the first patient was enrolled in the US clinical study for its Nautilus intrasaccular system. The goal of the TORNADO-US clinical research project was to evaluate the Nautilus Intrasaccular System, an innovative device for treating brain aneurysms. The patient was treated in New York at The Mount Sinai Hospital. In addition, Kaneka i-ED coils were utilized in conjunction with the Nautilus Intrasaccular System to treat the patient.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Neurovascular Devices Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product
    • 4.2.1. Cerebral Embolization and Aneurysm Coiling Devices
      • 4.2.1.1. Embolic Coils
      • 4.2.1.2. Flow Diversion Devices
      • 4.2.1.3. Liquid Embolic Agents
    • 4.2.2. Cerebral Angioplasty and Stenting Systems
      • 4.2.2.1. Carotid Artery Stents
      • 4.2.2.2. Embolic Protection
    • 4.2.3. Neurothrombectomy Devices
      • 4.2.3.1. Clot Retrieval Devices
      • 4.2.3.2. Suction Devices/Aspiration Catheters
      • 4.2.3.3. Vascular Snares
    • 4.2.4. Support Devices
      • 4.2.4.1. Micro Catheters
      • 4.2.4.2. Micro Guidewires
    • 4.2.5. Trans Radial Access Devices
  • 4.3. By Application
    • 4.3.1. Cerebral Aneurysm
    • 4.3.2. Ischemic Stroke
    • 4.3.3. Carotid Artery Stenosis
    • 4.3.4. Arteriovenous Malformation and Fistulas
    • 4.3.5. Others
  • 4.4. By Size
    • 4.4.1. 0.027 inches
    • 4.4.2. 0.021 inches
    • 4.4.3. 0.071 inches
    • 4.4.4. 0.017 inches
    • 4.4.5. Others
  • 4.5. By End-user
    • 4.5.1. Hospitals
    • 4.5.2. Ambulatory Surgical Centers
    • 4.5.3. Others
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia-Pacific
    • 4.6.4. South America
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Neurovascular Devices Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product
      • 5.1.2.1. Cerebral Embolization and Aneurysm Coiling Devices
        • 5.1.2.1.1. Embolic Coils
        • 5.1.2.1.2. Flow Diversion Devices
        • 5.1.2.1.3. Liquid Embolic Agents
      • 5.1.2.2. Cerebral Angioplasty and Stenting Systems
        • 5.1.2.2.1. Carotid Artery Stents
        • 5.1.2.2.2. Embolic Protection
      • 5.1.2.3. Neurothrombectomy Devices
        • 5.1.2.3.1. Clot Retrieval Devices
        • 5.1.2.3.2. Suction Devices/Aspiration Catheters
        • 5.1.2.3.3. Vascular Snares
      • 5.1.2.4. Support Devices
        • 5.1.2.4.1. Micro Catheters
        • 5.1.2.4.2. Micro Guidewires
      • 5.1.2.5. Trans Radial Access Devices
    • 5.1.3. By Application
      • 5.1.3.1. Cerebral Aneurysm
      • 5.1.3.2. Ischemic Stroke
      • 5.1.3.3. Carotid Artery Stenosis
      • 5.1.3.4. Arteriovenous Malformation and Fistulas
      • 5.1.3.5. Others
    • 5.1.4. By Size
      • 5.1.4.1. 0.027 inches
      • 5.1.4.2. 0.021 inches
      • 5.1.4.3. 0.071 inches
      • 5.1.4.4. 0.017 inches
      • 5.1.4.5. Others
    • 5.1.5. By End-user
      • 5.1.5.1. Hospitals
      • 5.1.5.2. Ambulatory Surgical Centers
      • 5.1.5.3. Others
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
        • 5.1.6.1.1. By Value
        • 5.1.6.1.2. By Volume
      • 5.1.6.2. By Product
        • 5.1.6.2.1. Cerebral Embolization and Aneurysm Coiling Devices
          • 5.1.6.2.1.1. Embolic Coils
          • 5.1.6.2.1.2. Flow Diversion Devices
          • 5.1.6.2.1.3. Liquid Embolic Agents
        • 5.1.6.2.2. Cerebral Angioplasty and Stenting Systems
          • 5.1.6.2.2.1. Carotid Artery Stents
          • 5.1.6.2.2.2. Embolic Protection
        • 5.1.6.2.3. Neurothrombectomy Devices
          • 5.1.6.2.3.1. Clot Retrieval Devices
          • 5.1.6.2.3.2. Suction Devices/Aspiration Catheters
          • 5.1.6.2.3.3. Vascular Snares
        • 5.1.6.2.4. Support Devices
          • 5.1.6.2.4.1. Micro Catheters
          • 5.1.6.2.4.2. Micro Guidewires
        • 5.1.6.2.5. Trans Radial Access Devices
      • 5.1.6.3. By Application
        • 5.1.6.3.1. Cerebral Aneurysm
        • 5.1.6.3.2. Ischemic Stroke
        • 5.1.6.3.3. Carotid Artery Stenosis
        • 5.1.6.3.4. Arteriovenous Malformation and Fistulas
        • 5.1.6.3.5. Others
      • 5.1.6.4. By Size
        • 5.1.6.4.1. 0.027 inches
        • 5.1.6.4.2. 0.021 inches
        • 5.1.6.4.3. 0.071 inches
        • 5.1.6.4.4. 0.017 inches
        • 5.1.6.4.5. Others
      • 5.1.6.5. By End-user
        • 5.1.6.5.1. Hospitals
        • 5.1.6.5.2. Ambulatory Surgical Centers
        • 5.1.6.5.3. Others
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Application
  • 6.3. By Size
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Medtronic Plc
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Penumbra Inc.
  • 13.3. Stryker Corporation
  • 13.4. Johnson & Johnson Services Inc.
  • 13.5. Microport Scientific Corporation
  • 13.6. Terumo Corporation
  • 13.7. Acandis GmbH
  • 13.8. NeuroVasc Technologies Inc.
  • 13.9. Asahi Intecc USA Inc.
  • 13.10. Integra Lifesciences Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 3. Global Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 6. Global Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Neurovascular Devices Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 10. North America Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 11. North America Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 12. North America Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 13. North America Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Neurovascular Devices Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 17. United States Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 18. United States Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 19. United States Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 20. United States Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 23. Canada Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 24. Canada Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 25. Canada Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 26. Canada Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 29. Mexico Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 30. Mexico Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 31. Mexico Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 32. Mexico Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 35. Europe Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 36. Europe Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 37. Europe Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 38. Europe Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Neurovascular Devices Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 42. Germany Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 43. Germany Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 44. Germany Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 45. Germany Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 48. France Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 49. France Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 50. France Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 51. France Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 54. Italy Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 55. Italy Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 56. Italy Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 57. Italy Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 60. United Kingdom Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 61. United Kingdom Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 62. United Kingdom Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 63. United Kingdom Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 66. Russia Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 67. Russia Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 68. Russia Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 69. Russia Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 72. Netherlands Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 73. Netherlands Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 74. Netherlands Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 75. Netherlands Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 78. Spain Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 79. Spain Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 80. Spain Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 81. Spain Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 84. Turkey Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 85. Turkey Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 86. Turkey Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 87. Turkey Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 90. Poland Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 91. Poland Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 92. Poland Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 93. Poland Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 96. South America Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 97. South America Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 98. South America Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 99. South America Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Neurovascular Devices Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 103. Brazil Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 104. Brazil Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 105. Brazil Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 106. Brazil Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 109. Argentina Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 110. Argentina Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 111. Argentina Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 112. Argentina Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 115. Asia-Pacific Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 116. Asia-Pacific Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 117. Asia-Pacific Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 118. Asia-Pacific Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Neurovascular Devices Market Share (%), By Country, 2017-2031F
  • Figure 120. India Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 122. India Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 123. India Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 124. India Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 125. India Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 128. China Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 129. China Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 130. China Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 131. China Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 134. Japan Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 135. Japan Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 136. Japan Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 137. Japan Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 140. Australia Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 141. Australia Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 142. Australia Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 143. Australia Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 146. Vietnam Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 147. Vietnam Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 148. Vietnam Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 149. Vietnam Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 152. South Korea Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 153. South Korea Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 154. South Korea Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 155. South Korea Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 158. Indonesia Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 159. Indonesia Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 160. Indonesia Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 161. Indonesia Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 164. Philippines Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 165. Philippines Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 166. Philippines Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 167. Philippines Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 170. Middle East & Africa Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 171. Middle East & Africa Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 172. Middle East & Africa Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 173. Middle East & Africa Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Neurovascular Devices Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 177. Saudi Arabia Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 178. Saudi Arabia Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 179. Saudi Arabia Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 180. Saudi Arabia Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 183. UAE Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 184. UAE Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 185. UAE Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 186. UAE Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Neurovascular Devices Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Neurovascular Devices Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 189. South Africa Neurovascular Devices Market Share (%), By Product, 2017-2031F
  • Figure 190. South Africa Neurovascular Devices Market Share (%), By Application, 2017-2031F
  • Figure 191. South Africa Neurovascular Devices Market Share (%), By Size, 2017-2031F
  • Figure 192. South Africa Neurovascular Devices Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Size Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023